Mark Kroll Biography and Net Worth

Director of Axon Enterprise

Mark W. Kroll Ph.D., FACC. Dr. Kroll retired from St. Jude Medical Inc. in July 2005, where he held various executive level positions since 1995, most recently as Senior Vice President and Chief Technology Officer, Cardiac Rhythm Management Division. Dr. Kroll holds a B.S. degree in Mathematics and a M.S. degree and a Ph.D. degree in Electrical Engineering from the University of Minnesota and a M.B.A. degree from the University of St. Thomas. He has over 340 issued US patents and is a Fellow of the: American College of Cardiology, Heart Rhythm Society, Institute of Electronics and Electrical Engineering, and the American Institute for Medicine and Biology in Engineering. Dr. Kroll is also a director of Haemonetics Corporation.

What is Mark W. Kroll's net worth?

The estimated net worth of Mark W. Kroll is at least $1.98 million as of March 7th, 2023. Dr. Kroll owns 10,142 shares of Axon Enterprise stock worth more than $1,981,950 as of September 23rd. This net worth estimate does not reflect any other assets that Dr. Kroll may own. Learn More about Mark W. Kroll's net worth.

How do I contact Mark W. Kroll?

The corporate mailing address for Dr. Kroll and other Axon Enterprise executives is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. Axon Enterprise can also be reached via phone at (480) 991-0797 and via email at [email protected]. Learn More on Mark W. Kroll's contact information.

Has Mark W. Kroll been buying or selling shares of Axon Enterprise?

Mark W. Kroll has not been actively trading shares of Axon Enterprise over the course of the past ninety days. Most recently, Mark W. Kroll sold 3,549 shares of the business's stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $220.73, for a transaction totalling $783,370.77. Following the completion of the sale, the director now directly owns 10,142 shares of the company's stock, valued at $2,238,643.66. Learn More on Mark W. Kroll's trading history.

Who are Axon Enterprise's active insiders?

Axon Enterprise's insider roster includes Jawad Ahsan (CFO), Brittany Bagley (CFO), Adriane Brown (Director), Julie Cullivan (Director), Michael Garnreiter (Director), Joshua Isner (CRO), Caitlin Kalinowski (Director), Mark Kroll (Director), Jeffrey Kunins (Insider), Luke Larson (President), Matthew McBrady (Director), Hadi Partovi (Director), and Patrick Smith (CEO). Learn More on Axon Enterprise's active insiders.

Are insiders buying or selling shares of Axon Enterprise?

In the last year, Axon Enterprise insiders bought shares 4 times. They purchased a total of 45,250 shares worth more than $8,735,200.00. In the last year, insiders at the biotechnology company sold shares 32 times. They sold a total of 516,224 shares worth more than $99,757,899.43. The most recent insider tranaction occured on September, 11th when Director Julie A Cullivan sold 515 shares worth more than $110,452.05. Insiders at Axon Enterprise own 6.1% of the company. Learn More about insider trades at Axon Enterprise.

Information on this page was last updated on 9/11/2023.

Mark W. Kroll Insider Trading History at Axon Enterprise

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/7/2023Sell3,549$220.73$783,370.7710,142View SEC Filing Icon  
6/8/2022Sell3,159$102.82$324,808.3813,691View SEC Filing Icon  
See Full Table

Mark W. Kroll Buying and Selling Activity at Axon Enterprise

This chart shows Mark W Kroll's buying and selling at Axon Enterprise by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Axon Enterprise Company Overview

Axon Enterprise logo
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence. Its products include TASER 7, TASER X26P, TASER X2, TASER Consumer devices, and related cartridges; on-officer body cameras, Axon Fleet in-car systems, and other devices; Axon Evidence digital evidence management software-as-a-service; Axon Signal enabled devices, as well as hardware extended warranties; and Axon docks, cartridges, and batteries. It sells its products through its direct sales force, distribution partners, online store, and third-party resellers. Axon Enterprise, Inc. has a strategic partnership with Fusus, Inc. to expand the capabilities of Axon Respond and the Fusus Real-Time Crime Center in the Cloud solution to provide agencies real-time operations situational awareness. The company was formerly known as TASER International, Inc. and changed its name to Axon Enterprise, Inc. in April 2017. Axon Enterprise, Inc. was incorporated in 1993 and is headquartered in Scottsdale, Arizona.
Read More

Today's Range

Now: $195.42
Low: $194.50
High: $197.57

50 Day Range

MA: $197.92
Low: $175.73
High: $216.06

2 Week Range

Now: $195.42
Low: $109.31
High: $229.95


369,204 shs

Average Volume

453,804 shs

Market Capitalization

$14.61 billion

P/E Ratio


Dividend Yield